Skip to main content
SpringerLink
Log in

Economic evaluation for pharmaceuticals in Germany

  • Editorial
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jönsson, B.: Time for a common standard for cost-effectiveness in Europe? Eur. J. Health Econ. 7(4), 223–224 (2006)

    Article  Google Scholar 

  2. Graf v.d. Schulenburg, J.-M.: Methods for determining cost-benefit relations for pharmaceuticals in Germany. Eur. J. Health Econ. 5(Suppl.) (2007)

  3. Jönsson, B.: Alan Williams and cost-benefit analysis in health care: comments on the paper by Robert Sugden. In: Mason, A., Towse, A. (eds.) The influence of Alan Williams. Be reasonable—do it my way! Radcliffe publishing, Oxford, New York (2007, in press)

Download references

Author information

Authors and Affiliations

  1. Stockholm School of Economics, Stockholm, Sweden

    Bengt Jönsson

Authors
  1. Bengt Jönsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bengt Jönsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jönsson, B. Economic evaluation for pharmaceuticals in Germany. Eur J Health Econ 8 (Suppl 1), 1–2 (2007). https://doi.org/10.1007/s10198-007-0066-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-007-0066-1

Search

Navigation